Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic azelastine + fluticasone nasal spray for seasonal allergic rhinitis
ChiCTR2300073758Phase 4Recruiting
- Sponsor
- Yulin No.2 Hospital
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of azelastine + fluticasone in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Yulin No.2 Hospital. Primary endpoints: Total nasal symptom score (TNSS) and Proportion of minimal symptom days. Started Jul 2023; status: recruiting.
02
Drugs
azelastine + fluticasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on ChiCTR2300073758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073758.